IVD Raw Materials
Sep 23, 2025
Keywords
Duration: 6 min
Chuanxin Liu, Ph.D
Dr. Chuanxin Liu earned his PhD in Biochemistry and has over a decade of extensive experience in immunology and virology. Since joining GenScript in 2020, he has been responsible for cell engineering, cell-based assays, and viral vectors for biologics characterization. Currently, he serves as a Senior Scientist in the R&D team, specializing in the advanced development of viral vector production.
Lentiviral vectors are widely used in gene therapy, functional genomics, and cell engineering due to their ability to stably integrate transgenes into the host genome of both dividing and non-dividing cells. This makes them ideal for long-term gene expression studies and therapeutic applications.
However, to ensure consistent and effective gene delivery, it is essential to determine the concentration of functional viral particles in a given preparation—a process known as lentiviral titering. Titer is typically expressed as Transducing Units per milliliter (TU/mL) and directly influences the efficiency, safety, and reproducibility of transduction protocols. Accurate titering allows researchers to optimize viral dosage, reduce unwanted cytotoxic effects, and standardize experiments across different batches and laboratories.
Comparison of Widely Used Lentiviral Titering Approaches
| Method | Fluorescence Required | Relative Accuracy | Turnaround Time | Best Use Case |
|---|---|---|---|---|
| p24 ELISA-Based Titering | No | ★★☆☆☆ | < 4 hours | Rapid, approximate estimation |
| Flow Cytometry (FACS)-Based Titering | Yes | ★★★★★ | ~3 days | Functional titer, high accuracy |
| qPCR-Based Titering | No | ★★★★★ | 3–4 days | Universal, precise quantification |
| Fluorescence Microscopy-Based Titering | Yes | ★★★☆☆ | 2–3 days | Preliminary or small-scale assays |
Multiple approaches are available for measuring lentiviral titer, each with specific advantages depending on the experimental design, cell type, and sensitivity requirements. Choosing the appropriate method ensures meaningful, reproducible results. The most commonly used titration techniques include:
1. p24 ELISA-Based Titering
Principle
The p24 ELISA assay quantifies the p24 capsid protein present in lentiviral particles, offering an indirect measure of total viral particle concentration. While it does not distinguish between infectious and non-infectious particles, it provides a useful estimate of overall viral load.
Workflow
Titer Calculation
| Advantages | Limitations |
|---|---|
|
|
2. Flow Cytometry (FACS)-Based Titering
Principle
This method quantifies functional viral particles by measuring the percentage of cells expressing a fluorescent reporter gene (such as GFP or RFP) using flow cytometry.
Workflow
Titer Calculation
| Advantages | Limitations |
|---|---|
|
|
3. qPCR-Based Titering
Principle
This method estimates infectious titer by quantifying viral genome sequences (e.g., LTR/WPRE) integrated into host genomic DNA using quantitative PCR (qPCR).
| Feature | Duplex Probe qPCR (Viral + Reference) | SYBR Green qPCR (Viral + Reference) | SYBR Green qPCR (Viral-only) |
|---|---|---|---|
| Sample type | Genomic DNA from transduced cells | Genomic DNA from transduced cells | Genomic DNA from transduced cells |
| Detection chemistry | Two probes with distinct fluorophores (viral + single-copy host gene) | DNA-binding dye detecting viral and reference amplicons (run in parallel wells) | DNA-binding dye detecting viral amplicon only |
| Normalization target | Single-copy host gene (e.g., RNase P, albumin, beta-globin) | Single-copy host gene (run separately) | None |
| Specificity | Very high (probe and primer ensure true viral + host signals) | Moderate (requires melt curve to confirm specificity) | Moderate (requires melt curve; primer-dimer risk) |
| Accuracy | High — absolute copies normalized per genome or per cell | Moderate — normalization possible but less robust due to parallel-well detection | Low — reports viral copies only, not per cell |
| Reproducibility | Strong (low inter-assay variation) | Weaker, depends on primer performance and melt curve validation | Weaker, no correction for DNA input differences |
| Sensitivity | High; reliable at low copy numbers | Good, but affected by nonspecific amplification | Good, but less robust at low viral copy per genome |
| Typical reported units | Viral copies per cell | Viral copies per cell | absolute viral copies per reaction (unnormalized) |
Workflow
Titer Calculation
| Advantages | Limitations |
|---|---|
|
|
4. Fluorescence Microscopy-Based Titering
Principle
This method estimates infectious titer by directly visualizing and counting cells expressing a fluorescent reporter protein using fluorescence microscopy, providing a rough measure of transduction efficiency.
Workflow
Titer Calculation
| Advantages | Limitations |
|---|---|
|
|
Droplet Digital PCR (ddPCR)
ddPCR partitions the PCR reaction into thousands of nanoliter-sized droplets, allowing absolute quantification of viral genomes without reliance on standard curves. This enhances sensitivity and precision, making it ideal for detecting low-abundance viral sequences and providing highly reproducible titer measurements.
Surface-Enhanced Raman Spectroscopy (SERS)
SERS leverages the enhancement of Raman scattering signals by metallic nanostructures to detect viral particles rapidly and without labels. This technique offers a fast, non-destructive approach to quantify lentiviral particles based on their unique molecular fingerprints, enabling real-time monitoring with minimal sample preparation.
Accurate and reliable quantification of functional lentiviral titer is essential for ensuring successful gene delivery and meaningful experimental outcomes. Each titration method—whether p24 ELISA, FACS, qPCR, or fluorescence microscopy—offers distinct advantages and limitations in measuring infectious units. Among these methods, qPCR-based titering is widely valued for its high precision, sensitivity, and reproducibility in quantifying functional lentiviral particles. Its ability to directly measure integrated viral genomes makes it especially suitable for accurately determining infectious units.
Aligned with this technological standard, GenScript has integrated duplex probe qPCR into its quality control system for lentiviral packaging services. This method provides exceptional accuracy and reproducibility in determining functional titers by simultaneously amplifying viral and reference genes, correcting for variations in sample quality and ensuring results are both reliable and comparable across batches.
Leveraging the third-generation self-inactivating (SIN) lentiviral system, GenScript offers a one-stop lentivirus packaging solution from vector design, gene synthesis to virus packaging and purification, accelerating your gene therapy research. Our core advantages include:
Interested in learning more about GenScript Lentivirus Packaing Service? Click the button below to learn more and get in touch with us — we’re here to help!
1. GenScript. Lentiviral Titer p24 ELISA kit.
2. MD Anderson Cancer Center. Lentivirus Titering Protocol. Technical Manual, 2022.
3. Sena-Esteves, et al. Titration of lentivirus vectors. Cold Spring Harbor Protocols 2018, no. 4 (2018): pdb-prot095695.
4. Barczak W, et al. Universal real-time PCR-based assay for lentiviral titration. Molecular Biotechnology. 2014;57:195–200.
5. Addgene. ddPCR Titration of Lentivirus Vectors. Protocol.
6. Kandell J, et al. Universal ddPCR-based assay for determining lentivirus infectious titer and vector copy number. Molecular Therapy – Methods & Clinical Development. 2023;30:273–283.
7. Morder C, et al. Determination of Lentiviral Titer by Surface Enhanced Raman Scattering. Anal Methods. 2022 Apr 7;14(14):1387–1395